S-1: Mullen Automotive Files S-1 for Resale of 10 Million Shares Amid Ongoing Financing Activities

Mullen Automotive is registering for resale up to 10 million shares of its common stock by selling stockholders, derived from convertible notes and warrants.

Summary

• Mullen Automotive has filed a Form S-1 registration statement with the SEC to allow selling stockholders to resell up to 10,000,000 shares of the company's common stock.
• These shares are issuable upon conversion of convertible notes and exercise of warrants previously issued under Securities Purchase Agreements dated May 14, 2024, and January 23, 2025.
• As of February 28, 2025, approximately $18.9 million in principal and interest of Notes were outstanding, convertible into 7,605,837 shares of Common Stock, along with warrants exercisable for 1,665,400 shares.
• These amounts represent approximately 78% beneficial ownership of the shares of Common Stock outstanding as of that date.
• The company will not receive any proceeds from the sale of these shares by the selling stockholders, except from any cash exercise of the warrants.
• Mullen Automotive is a smaller reporting company and is subject to reduced public company reporting requirements.
• The company's stock is listed on the Nasdaq Capital Market under the symbol MULN, with a last reported sale price of $2.06 per share on March 3, 2025.

Sentiment

Score: 4

Explanation: The document is primarily factual and descriptive, outlining the terms of the share resale and related financial agreements. The sentiment is neutral, with some caution due to the risks associated with the company's financial situation and potential dilution.

Positives

• Registration allows selling stockholders to offer shares for resale, potentially increasing liquidity.
• The company may receive proceeds from the cash exercise of warrants, which would be used for general working capital.

Negatives

• The company will not receive any proceeds from the resale of shares by the selling stockholders, other than any proceeds from any cash exercise of the Warrants.
• The potential sale of a large number of shares by selling stockholders could negatively impact the stock price.
• The company is a smaller reporting company, which may limit the amount of information available to investors.

Risks

• Investment in the company's securities involves a high degree of risk.
• The selling stockholders may sell a large number of shares, potentially diminishing the value of shares held by current stockholders.
• The company's outstanding shares of convertible preferred stock contain anti-dilution protection, which may cause significant dilution to common stockholders.
• The company's commitments to issue shares of Common Stock or securities that are convertible into shares of Common Stock may cause significant dilution to our stockholders.
• The company may not be able to maintain compliance with the continued listing requirements of the NASDAQ Capital Market.
• The Selling Stockholders may participate in short sales of our Common Stock, which could cause a decline in the market price of the shares of our Common Stock.

Future Outlook

The company is registering additional shares of Common Stock that may be issuable under the conversion, exercise and anti-dilution provisions contained in the terms of the Notes and Warrants.

Industry Context

The document positions Mullen Automotive as a Southern California-based technology and automotive company focused on building and delivering commercial trucks, with a strategy of opportunistic acquisitions to enter the EV market.

Comparison to Industry Standards

• The document does not provide specific comparisons to industry standards or competitors.
• However, it mentions acquisitions like Bollinger Motors and ELMS, suggesting a strategy to compete in the commercial EV truck market.
• The document states that Mullen believes there is very little current competition and, in some segments, no other announced entries in the Commercial EV truck market with vehicles ranging from Class 1 to 6.

Related Party Transactions

• On May 21, 2024, the Company entered into the ELOC Purchase Agreement with Esousa, pursuant to which Esousa has agreed to purchase from the Company, at the Company's direction from time to time, in its sole discretion, from and after July 5, 2024, and until the earlier of (i) the 36-month anniversary of the commencement date of July 16, 2024, or (ii) the termination of the ELOC Purchase Agreement in accordance with the terms thereof, shares of Common Stock, having a total maximum aggregate purchase price of $150,000,000, upon the terms and subject to the conditions and limitations set forth therein.

Stakeholder Impact

• Existing shareholders may experience dilution if the warrants and convertible notes are exercised.
• The potential sale of a large number of shares by selling stockholders could negatively impact the stock price.
• The company's ability to raise additional capital in the future could be affected by the resale of shares.

Next Steps

• The selling stockholders may offer the shares for resale from time to time.
• The company may receive proceeds from the exercise of the Warrants and issuance of the shares of our Common Stock issuable upon exercise of the Warrants.
• The Company has agreed to hold a meeting of its stockholders for the purpose of obtaining such stockholder approval.

Key Dates